|
Wangsu Science & Technology Co., Ltd. (300017.sz) DCF -Bewertung
CN | Technology | Software - Infrastructure | SHZ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Wangsu Science & Technology Co.,Ltd. (300017.SZ) Bundle
Entdecken Sie den wahren Wert von Wangsu Science & Technology Co., Ltd. (300017SZ) mit unserem fortschrittlichen DCF -Taschenrechner! Passen Sie die wichtigsten Annahmen an, erkunden Sie verschiedene Szenarien und beurteilen Sie, wie unterschiedliche Änderungen die Bewertung der Wangsu -Wissenschaft beeinflussen & Technology Co., Ltd. (300017SZ) - Alles innerhalb einer bequemen Excel -Vorlage.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6,007.5 | 5,686.6 | 4,575.0 | 5,084.2 | 4,705.5 | 4,456.0 | 4,219.8 | 3,996.0 | 3,784.2 | 3,583.5 |
| Revenue Growth, % | 0 | -5.34 | -19.55 | 11.13 | -7.45 | -5.3 | -5.3 | -5.3 | -5.3 | -5.3 |
| EBITDA | 650.0 | 782.4 | 657.5 | 668.4 | 1,016.3 | 656.8 | 622.0 | 589.0 | 557.8 | 528.2 |
| EBITDA, % | 10.82 | 13.76 | 14.37 | 13.15 | 21.6 | 14.74 | 14.74 | 14.74 | 14.74 | 14.74 |
| Depreciation | 580.9 | 549.2 | 514.7 | 430.7 | 353.4 | 415.0 | 393.0 | 372.1 | 352.4 | 333.7 |
| Depreciation, % | 9.67 | 9.66 | 11.25 | 8.47 | 7.51 | 9.31 | 9.31 | 9.31 | 9.31 | 9.31 |
| EBIT | 69.1 | 233.2 | 142.8 | 237.7 | 662.9 | 241.8 | 229.0 | 216.9 | 205.4 | 194.5 |
| EBIT, % | 1.15 | 4.1 | 3.12 | 4.68 | 14.09 | 5.43 | 5.43 | 5.43 | 5.43 | 5.43 |
| Total Cash | 4,067.5 | 3,799.3 | 4,666.8 | 4,713.0 | 4,531.4 | 3,774.4 | 3,574.3 | 3,384.8 | 3,205.3 | 3,035.4 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 1,694.7 | 1,704.1 | 1,372.8 | 1,268.9 | 1,102.7 | 1,217.2 | 1,152.6 | 1,091.5 | 1,033.6 | 978.8 |
| Account Receivables, % | 28.21 | 29.97 | 30.01 | 24.96 | 23.43 | 27.32 | 27.32 | 27.32 | 27.32 | 27.32 |
| Inventories | 10.3 | 6.1 | 12.2 | 30.5 | 13.5 | 12.7 | 12.1 | 11.4 | 10.8 | 10.3 |
| Inventories, % | 0.17132 | 0.10652 | 0.26565 | 0.60035 | 0.28648 | 0.28606 | 0.28606 | 0.28606 | 0.28606 | 0.28606 |
| Accounts Payable | 879.5 | 708.0 | 705.5 | 748.3 | 568.0 | 617.6 | 584.9 | 553.9 | 524.5 | 496.7 |
| Accounts Payable, % | 14.64 | 12.45 | 15.42 | 14.72 | 12.07 | 13.86 | 13.86 | 13.86 | 13.86 | 13.86 |
| Capital Expenditure | -803.5 | -414.8 | -255.0 | -188.7 | -86.7 | -283.4 | -268.4 | -254.1 | -240.7 | -227.9 |
| Capital Expenditure, % | -13.38 | -7.29 | -5.57 | -3.71 | -1.84 | -6.36 | -6.36 | -6.36 | -6.36 | -6.36 |
| Tax Rate, % | 5.88 | 5.88 | 5.88 | 5.88 | 5.88 | 5.88 | 5.88 | 5.88 | 5.88 | 5.88 |
| EBITAT | 110.0 | 235.0 | 171.3 | 233.5 | 623.9 | 238.1 | 225.5 | 213.5 | 202.2 | 191.5 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -938.1 | 192.7 | 753.8 | 603.7 | 893.6 | 305.5 | 382.6 | 362.3 | 343.1 | 324.9 |
| WACC, % | 6.11 | 6.11 | 6.11 | 6.11 | 6.11 | 6.11 | 6.11 | 6.11 | 6.11 | 6.11 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 1,443.0 | |||||||||
| Long Term Growth Rate, % | 3.50 | |||||||||
| Free cash flow (T + 1) | 336 | |||||||||
| Terminal Value | 12,874 | |||||||||
| Present Terminal Value | 9,570 | |||||||||
| Enterprise Value | 11,013 | |||||||||
| Net Debt | -1,711 | |||||||||
| Equity Value | 12,724 | |||||||||
| Diluted Shares Outstanding, MM | 2,452 | |||||||||
| Equity Value Per Share | 5.19 |
What You Will Receive
- Authentic Wangsu Data: Preloaded financials – from revenue to EBIT – derived from real and projected figures.
- Comprehensive Customization: Modify all essential parameters (yellow cells) such as WACC, growth %, and tax rates as needed.
- Instant Valuation Adjustments: Automatic recalculations to evaluate the effects of changes on Wangsu’s fair value.
- Flexible Excel Template: Designed for easy edits, scenario analysis, and detailed forecasting.
- Efficient and Precise: Eliminate the need to build models from scratch while ensuring accuracy and adaptability.
Key Features
- 🔍 Real-Life Wangsu Financials: Pre-filled historical and projected data for Wangsu Science & Technology Co., Ltd. (300017SZ).
- ✏️ Fully Customizable Inputs: Modify all essential parameters (yellow cells) such as WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Integrated formulas compute Wangsu's intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: View Wangsu's valuation instantly after any adjustments.
- Scenario Analysis: Evaluate and contrast outcomes for different financial assumptions side-by-side.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review the pre-filled data for Wangsu Science & Technology Co., Ltd. (300017SZ) including historical and projected figures.
- Step 3: Modify the key assumptions (highlighted in yellow) according to your analysis.
- Step 4: Observe the automatic recalculations reflecting the intrinsic value of Wangsu Science & Technology Co., Ltd. (300017SZ).
- Step 5: Utilize the outputs for your investment strategies or reporting needs.
Why Choose Wangsu Science & Technology Co., Ltd. Calculator?
- Precision: Utilizes authentic Wangsu financial data to ensure reliable results.
- Customizability: Allows users to easily adjust and experiment with various inputs.
- Efficiency: Eliminate the complexities of creating a DCF model from the ground up.
- High-Quality: Crafted with the accuracy and functionality expected by top-tier financial professionals.
- Intuitive: Designed for straightforward use, accessible even for those new to financial modeling.
Who Should Use This Product?
- Professional Investors: Develop comprehensive and reliable valuation models to assess portfolio performance for Wangsu Science & Technology Co.,Ltd. (300017SZ).
- Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decision-making within the organization.
- Consultants and Advisors: Equip clients with precise valuation insights pertaining to Wangsu Science & Technology Co.,Ltd. (300017SZ).
- Students and Educators: Leverage real-world data to enhance learning and practice in financial modeling.
- Tech Enthusiasts: Gain insights into the market valuation of technology firms like Wangsu Science & Technology Co.,Ltd. (300017SZ).
Contents of the Template
- Pre-Filled DCF Model: Wangsu Science & Technology Co., Ltd.'s financial data preloaded for immediate analysis.
- WACC Calculator: Comprehensive calculations for the Weighted Average Cost of Capital.
- Financial Ratios: Assess Wangsu's profitability, leverage, and operational efficiency.
- Editable Inputs: Modify assumptions such as growth rates, margins, and capital expenditures to suit your needs.
- Financial Statements: Access annual and quarterly reports for thorough examination.
- Interactive Dashboard: Effortlessly visualize essential valuation metrics and outcomes.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.